105438 |
NEURO-ONCOLOGY |
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma |
2012-10-22 |
10.1093/neuonc/nos256 |
Franceschi E., Stupp R., van den Bent M. J., van Herpen C., Laigle Donadey F., Gorlia T., Hegi M., Lhermitte B., Strauss L. C., Allgeier A., Lacombe D., Brandes A. A. |
105437 |
NEURO-ONCOLOGY |
The molecular biology of WHO grade I astrocytomas |
2012-10-22 |
10.1093/neuonc/nos257 |
Marko N. F., Weil R. J. |
105436 |
NEURO-ONCOLOGY |
Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group |
2012-10-22 |
10.1093/neuonc/nos263 |
Yan Wei, Zhang Wei, You Gan, Zhang Junxia, Han Lei, Bao Zhaoshi, Wang Yongzhi, Liu Yanwei, Jiang Chuanlu, Kang Chunsheng, You Yongping, Jiang Tao |
105435 |
CANCERS |
High Resolution Fluorescence Imaging of Cancers Using Lanthanide Ion-Doped Upconverting Nanocrystals |
2012-10-22 |
10.3390/cancers4041067 |
Naccache Rafik, Rodríguez Emma Martín, Bogdan Nicoleta, Sanz-Rodríguez Francisco, Cruz Maria del Carmen Iglesias de la, Fuente Ángeles Juarranz de la, Vetrone Fiorenzo, Jaque Daniel, Solé José García, Capobianco John A. |
105434 |
BMC EVOLUTIONARY BIOLOGY |
The independent prokaryotic origins of eukaryotic fructose-1, 6-bisphosphatase and sedoheptulose-1, 7-bisphosphatase and the implications of their origins for the evolution of eukaryotic Calvin cycle |
2012-10-22 |
10.1186/1471-2148-12-208 |
Jiang Yong-Hai, Wang De-Yong, Wen Jian-Fan |
105433 |
NEURO-ONCOLOGY |
Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation |
2012-10-22 |
10.1093/neuonc/nos258 |
Lazovic J., Soto H., Piccioni D., Lo Ru J. R., Li S., Mirsadraei L., Yong W., Prins R., Liau L. M., Ellingson B. M., Cloughesy T. F., Lai A., Pope W. B. |
105432 |
BMC CANCER |
A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples |
2012-10-22 |
10.1186/1471-2407-12-486 |
Dimitrakopoulos Lampros, Vorkas Panagiotis A, Georgoulias Vasilis, Lianidou Evi S |
105431 |
NEURO-ONCOLOGY |
Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [18F]FET-PET imaging in intracranial WHO grade II and III gliomas |
2012-10-22 |
10.1093/neuonc/nos259 |
Jansen N. L., Schwartz C., Graute V., Eigenbrod S., Lutz J., Egensperger R., Popperl G., Kretzschmar H. A., Cumming P., Bartenstein P., Tonn J.-C., Kreth F.-W., la Fougere C., Thon N. |
105430 |
EXPERIMENTAL AND THERAPEUTIC MEDICINE |
Ultrasonically enhanced rifampin activity against internalized Staphylococcus aureus |
2012-10-22 |
10.3892/etm.2012.758 |
SHI SI-FENG, ZHANG XIAN-LONG, ZHU CHEN, CHEN DE-SHENG, GUO YONG-YUAN |
105429 |
EXPERIMENTAL AND THERAPEUTIC MEDICINE |
Effect of alendronate sodium on the expression of mesenchymal-epithelial transition markers in mice with liver fibrosis |
2012-10-22 |
10.3892/etm.2012.759 |
BI WAN-RONG, JIN CAI-XIA, XU GUO-TONG, YANG CHANG-QING |